Dr. Stefan Anker and Dr. C. Michael Gibson Discuss: EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalizations in patients with heart failure with a preserved ejection fraction, with and without diabetes August 27, 2021 2021 | Cardiology | ESC | Slides | Video Tags: 2021, Cardiology, ESC, slides, video Loading… Taking too long? Reload document | Open in new tab Download Disclosures: TBD Article Navigation Dr. Johanne Silvain Presents: Ticagrelor versus Clopidogrel in Elective Percutaneous Coronary Intervention : The Alpheus Trial Dr. Axel Bauer and Dr. Yaz Daaboul Discuss: Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction – A randomized trial
Reload document 
Open in new tab